Further, we verified our hypothesis and injected anti-DLL4 conjugated TNPs (0.75-1 mg/Kg of DLL4 antibody) in SSIL2Rγ- strain with MDA MB 231 and HCC 1806 tumors. The gene discussed is DLL4; the disease is hepatocellular carcinoma.